Vildagliptin Versus Sitagliptin - Differences in Fasting Plasma Glucose Lowering Efficacy

计划入组 187 人 · 首次发布于 2011 年 7 月 20 日

Relationship Between HbA1c, Fasting Plasma Glucose, Post-prandial Glucose and Other Measures of Glycemic Control

计划入组 100 人 · 首次发布于 2014 年 4 月 17 日

Evaluation of Innovated Screening Tools for Type 2 Diabetes Among Chinese Population(SENSIBLE STUDY I)

计划入组 20,000 人 · 首次发布于 2017 年 1 月 20 日

Glucose(Bss Ophthalmic Solution, Citrasate, Clinimix 2.75/5, Clinimix E 2.75/5, Dextroject, Dianeal, H.E.L.P.bicel, Hemosate Ultra, Lactate 1-2-3, Leukotrap, Naturalyte, Nauzene, Normosol-R, Nxstage Pureflow, Olimel, Periolimel, Physioneal 40, Sag-M, Sclerodex, Selectbag One)

Rx

cefoxitin;glucose

D-glucose(As 3, Cpda-1 Blood Collection System, Dextrose and Electrolyte No. 75, Dianeal Low Calcium 1.5, Dianeal Pd-2/1.5, Ionosol-MB, Isolyte P, Leukotrap, Normosol-M, Plasma-lyte 148 In 5 % Dextrose, Prismasol)

C₆H₁₂O₆

Octapharma Plasma, Inc.

United States

Biopharma Plasma LLC

THE PLASMA SOURCE

United States

Fasting Plasma Glucose Emerges as Key Predictor in 10-Year Diabetes Risk Assessment Study

UP Manila Researchers Develop Ampalaya Tablet as Herbal Medicine for Type 2 Diabetes

Study Highlights Efficacy and Safety of SGLT2 Inhibitors in Type 2 Diabetes Management